Staar Surgical Co STAA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand
-
Sidoti Events, LLC's Virtual September Small-Cap Conference
-
STAAR Surgical Reports Second Quarter 2024 Results
-
STAAR Surgical to Report Second Quarter Results on August 7, 2024
-
STAAR Surgical to Participate in Canaccord Genuity 44th Annual Growth Conference
-
These small-cap stocks score highest when screened for quality
-
These small-cap stocks score highest when -2-
Trading Information
- Previous Close Price
- $34.16
- Day Range
- $33.96–35.50
- 52-Week Range
- $26.66–52.68
- Bid/Ask
- $34.72 / $35.35
- Market Cap
- $1.73 Bil
- Volume/Avg
- 562,579 / 815,424
Key Statistics
- Price/Earnings (Normalized)
- 39.66
- Price/Sales
- 5.07
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.09%
Company Profile
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,115
- Website
- https://www.staar.com
Comparables
Valuation
|
Metric
|
STAA
|
RXST
|
688050
|
|---|---|---|---|
Price/Earnings (Normalized) | 39.66 | — | 55.71 |
Price/Book Value | 4.10 | 6.89 | 8.35 |
Price/Sales | 5.07 | 15.26 | 15.33 |
Price/Cash Flow | 32.86 | — | 39.17 |
Price/Earnings
STAA
RXST
688050
Financial Strength
|
Metric
|
STAA
|
RXST
|
688050
|
|---|---|---|---|
Quick Ratio | 5.00 | 13.20 | 3.05 |
Current Ratio | 5.80 | 14.33 | 3.92 |
Interest Coverage | — | −178.67 | 25.94 |
Quick Ratio
STAA
RXST
688050
Profitability
|
Metric
|
STAA
|
RXST
|
688050
|
|---|---|---|---|
Return on Assets (Normalized) | 7.47% | −7.66% | 99.47% |
Return on Equity (Normalized) | 9.36% | −8.75% | 138.18% |
Return on Invested Capital (Normalized) | 7.38% | −11.24% | 108.06% |
Return on Assets
STAA
RXST
688050
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Bjwcbskrq | Mgyvf | $170.4 Bil | |||
| Becton Dickinson & Co
BDX
| Ncsjchynh | Qrjsbd | $68.6 Bil | |||
| Alcon Inc
ALC
| Ctnvghl | Wjfqcj | $48.7 Bil | |||
| ResMed Inc
RMD
| Xwgtddyvk | Pybzqrl | $35.0 Bil | |||
| Coloplast AS ADR
CLPBY
| Hddvdxhch | Ltvr | $29.2 Bil | |||
| West Pharmaceutical Services Inc
WST
| Snljtrwt | Lygc | $21.6 Bil | |||
| The Cooper Companies Inc
COO
| Rztsrpr | Nzrzmw | $21.3 Bil | |||
| Hologic Inc
HOLX
| Yjzwhyt | Kjhpbjy | $18.4 Bil | |||
| Baxter International Inc
BAX
| Zsdpppjg | Hvylwjh | $17.9 Bil | |||
| Align Technology Inc
ALGN
| Msrgllfsh | Ygydr | $17.7 Bil |
United States